A detailed history of Hnp Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Hnp Capital LLC holds 2,078 shares of ABBV stock, worth $356,854. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,078
Previous 2,163 3.93%
Holding current value
$356,854
Previous $349,000 5.16%
% of portfolio
0.09%
Previous 0.1%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 18, 2023

SELL
$144.61 - $166.54 $12,291 - $14,155
-85 Reduced 3.93%
2,078 $331,000
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $18,789 - $21,550
-140 Reduced 6.08%
2,163 $290,000
Q1 2022

Aug 15, 2022

SELL
$131.98 - $163.75 $2.39 Million - $2.96 Million
-18,099 Reduced 88.71%
2,303 $373,000
Q1 2022

May 02, 2022

BUY
$131.98 - $163.75 $2.38 Million - $2.95 Million
18,024 Added 757.95%
20,402 $3.31 Million
Q4 2021

Jan 18, 2022

BUY
$107.43 - $135.93 $10,743 - $13,593
100 Added 4.39%
2,378 $322,000
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $10,640 - $12,078
-100 Reduced 4.21%
2,278 $246,000
Q1 2021

May 28, 2021

SELL
$102.3 - $112.62 $13,708 - $15,091
-134 Reduced 5.33%
2,378 $257,000
Q4 2020

Feb 10, 2021

SELL
$80.49 - $108.67 $10,061 - $13,583
-125 Reduced 4.74%
2,512 $269,000
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $6,099 - $7,158
71 Added 2.77%
2,637 $245,000
Q2 2020

Jul 06, 2020

SELL
$73.37 - $98.18 $1.21 Million - $1.62 Million
-16,515 Reduced 86.55%
2,566 $254,000
Q1 2020

Apr 22, 2020

BUY
$64.5 - $97.79 $1.04 Million - $1.57 Million
16,082 Added 536.25%
19,081 $1.45 Million
Q4 2019

Jan 13, 2020

BUY
$72.13 - $90.25 $216,317 - $270,659
2,999 New
2,999 $267,000
Q2 2019

Jul 16, 2019

SELL
$65.7 - $83.98 $170,425 - $217,844
-2,594 Closed
0 $0
Q1 2019

Apr 24, 2019

SELL
$77.14 - $90.79 $15,428 - $18,158
-200 Reduced 7.16%
2,594 $209,000
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $217,512 - $268,251
2,794 New
2,794 $257,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hnp Capital LLC Portfolio

Follow Hnp Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hnp Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hnp Capital LLC with notifications on news.